Gotham Asset Management »

Catalyst Pharmaceutical Partners shares owned by Gotham Asset Management

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Gotham Asset Management from 13F filings

Historical chart of Gotham Asset Management investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Gotham Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Gotham Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $561k 35k 15.94
2023-12-31 $630k 38k 16.81
2023-09-30 $1.3M 114k 11.69
2023-06-30 $1.5M 111k 13.44
2023-03-31 $2.3M 140k 16.58
2022-12-31 $354k 19k 18.60
2022-09-30 $644k 50k 12.84
2020-09-30 $97k 33k 2.97
2020-06-30 $323k 70k 4.62
2020-03-31 $489k 127k 3.85
2019-12-31 $137k 37k 3.75
2019-09-30 $211k 40k 5.30

More positions owned by Gotham Asset Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tidal Etf Tr Gotham Enhncd (GSPY)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Snowflake Cl A (SNOW)
Alphabet Cap Stk Cl A (GOOGL)
Tidal Etf Tr Gotham 1000 Valu (GVLU)
Amazon (AMZN)
Meta Platforms Cl A (META)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Core Msci Emkt (IEMG)
Qualcomm (QCOM)
Johnson & Johnson (JNJ)

View all positions for Gotham Asset Management

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Henderson Group
Geode Capital Management
Royce & Associates
Morgan Stanley
Marshall Wace
Robeco Investment Management
Northern Trust
Jacobs Levy Equity Management
T. Rowe Price Associates
Citadel Advisors
Voloridge Investment Management

View all funds holding Catalyst Pharmaceutical Partners